SEC Filings

8-K
ENVISION HEALTHCARE CORP filed this Form 8-K on 11/13/2017
Entire Document
 
Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2017

 

 

 

LOGO

ENVISION HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-37955   62-1493316

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1A Burton Hills Boulevard

Nashville, Tennessee

  37215
(Address of principal executive offices)   (Zip Code)

(615) 665-1283

(Each registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 7.01. Regulation FD Disclosure.

On November 13, 2017, Envision Healthcare Corporation, a Delaware corporation (the “Company”) posted an investor presentation to its website, which will be discussed in meetings with investors. A copy of the presentation is furnished as Exhibit 99.1 to this Form 8-K.

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description of Exhibit

99.1    November 2017 Investor Update.


EXHIBIT INDEX

 

Exhibit
No.

  

Description of Exhibit

99.1    November 2017 Investor Update.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Envision Healthcare Corporation has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ENVISION HEALTHCARE CORPORATION
November 13, 2017     By:  

/s/ Kevin D. Eastridge

    Name:   Kevin D. Eastridge
    Title:   Executive Vice President and Chief Financial Officer